ID: ALA3260675

Max Phase: Preclinical

Molecular Formula: C15H14N2O3

Molecular Weight: 270.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)/C=C/CNC(=O)c1ccc2ccccc2n1

Standard InChI:  InChI=1S/C15H14N2O3/c1-20-14(18)7-4-10-16-15(19)13-9-8-11-5-2-3-6-12(11)17-13/h2-9H,10H2,1H3,(H,16,19)/b7-4+

Standard InChI Key:  KEWKDCWAKOSBDI-QPJJXVBHSA-N

Associated Targets(non-human)

Human rhinovirus A protease 1343 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.29Molecular Weight (Monoisotopic): 270.1004AlogP: 1.69#Rotatable Bonds: 4
Polar Surface Area: 68.29Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.53CX LogP: 2.13CX LogD: 2.13
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.68Np Likeness Score: -0.40

References

1. Kathman SG, Xu Z, Statsyuk AV..  (2014)  A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.,  57  (11): [PMID:24870364] [10.1021/jm500345q]

Source